Managers / Q1 2025 · view latest →
Estuary Capital Management LP
CIK 0001965005 · 308 WALKER AVENUE SOUTH, WAYZATA, MN, 55391 · 203-300-7866
Summary
Estuary Capital Management LP reported $412M in U.S.-listed holdings across 14 positions for Q1 2025.
Its largest position, DLTR, represents 12.3% of the portfolio.
Compared with Q4 2024, the fund opened 6 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.7% · $374M
- Other · 9.3% · $38M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| UNHUNITEDHEALTH GRP ORD | NEW | +95.3K | 95.3K | +$50M | $50M |
| AAPLAPPLE ORD | NEW | +172.5K | 172.5K | +$38M | $38M |
| METAMETA PLATFORMS CL A ORD | NEW | +37.9K | 37.9K | +$22M | $22M |
| FICOFAIR ISAAC ORD | NEW | +10.9K | 10.9K | +$20M | $20M |
| UHSUNIVERSAL HEALTH SERVICES CL B ORD | NEW | +68.8K | 68.8K | +$13M | $13M |
| NVDANVIDIA ORD | NEW | +96.6K | 96.6K | +$10M | $10M |
| COKECOCA COLA CONS INC | SOLD OUT | −34.0K | 0 | −$43M | $0 |
| CROXCROCS INC | SOLD OUT | −26.1K | 0 | −$3M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | DLTRDOLLAR TREE INChistory → | COM | 12.34% | $51M | 677.7K |
| 2 | UNHUNITEDHEALTH GRP ORDhistory → | COM | 12.11% | $50M | 95.3K |
| 3 | AWNADVANCE AUTO PARTS INChistory → | COM | 11.97% | $49M | 1.26M |
| 4 | DGDOLLAR GEN CORP NEWhistory → | COM | 10.43% | $43M | 488.8K |
| 5 | JAZZ PHARMACEUTICALS PLC | SHS USD | 9.33% | $38M | 309.8K |
| 6 | AAPLAPPLE ORDhistory → | COM | 9.30% | $38M | 172.5K |
| 7 | GPNGLOBAL PMTS INChistory → | COM | 7.57% | $31M | 318.4K |
| 8 | DAWNGBXDAY ONE BIOPHARMACEUTICALS Ihistory → | COM | 6.40% | $26M | 3.33M |
| 9 | METAMETA PLATFORMS CL A ORDhistory → | CL A | 5.30% | $22M | 37.9K |
| 10 | FICOFAIR ISAAC ORDhistory → | COM | 4.87% | $20M | 10.9K |
| 11 | RPDRAPID7 INChistory → | COM | 3.50% | $14M | 544.1K |
| 12 | UHSUNIVERSAL HEALTH SERVICES CL B ORDhistory → | CL B | 3.14% | $13M | 68.8K |
| 13 | NVDANVIDIA ORDhistory → | COM | 2.54% | $10M | 96.6K |
| 14 | TAPMOLSON COORS BEVERAGE COhistory → | CL B | 1.20% | $5M | 81.1K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $598M | 22 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $562M | 23 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $563M | 16 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $513M | 13 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $412M | 14 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $342M | 10 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $373M | 16 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $310M | 17 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $246M | 16 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $165M | 18 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.